UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Shortened Courses of Antibiotics for Bacterial Infections: A Systematic Review of Randomized Controlled Trials

Pharmacotherapy, 2018-06, Vol.38 (6), p.674-687

2018

Volltextzugriff (PDF)

Vancomycin-resistant enterococcal bacteremia pharmacotherapy

The Annals of pharmacotherapy, 2015-01, Vol.49 (1), p.69-85

2015

Volltextzugriff (PDF)

Drug Fever

Pharmacotherapy, 2010-01, Vol.30 (1), p.57-69

2010

Volltextzugriff (PDF)

Allergic cross-sensitivity between penicillin, carbapenem, and monobactam antibiotics: what are the chances?

The Annals of pharmacotherapy, 2009-02, Vol.43 (2), p.304-315

2009

Volltextzugriff (PDF)

Taking on the Fundamental Questions in Infectious Diseases Two-at-a-Time

Clinical infectious diseases, 2023-05, Vol.76 (9), p.1613-1614

Gallagher, Jason C

2023

Volltextzugriff (PDF)

Lack of Benefit of Fluvoxamine for COVID-19

JAMA : the journal of the American Medical Association, 2023-01, Vol.329 (4), p.291

2023

Volltextzugriff (PDF)

Bacteria Keep Reminding Us: There Are No Silver Bullets

Clinical infectious diseases, 2020-12, Vol.71 (10), p.2717-2718

Gallagher, Jason C

2020

Volltextzugriff (PDF)

Beta-Lactam Hypersensitivity and Cross-Reactivity

Journal of pharmacy practice, 2014-12, Vol.27 (6), p.530-544

2014

Volltextzugriff (PDF)

β-lactam/β-lactamase inhibitor combinations: from then to now

The Annals of pharmacotherapy, 2015-01, Vol.49 (1), p.86-98

2015

Volltextzugriff (PDF)

Eravacycline: The Tetracyclines Strike Back

The Annals of pharmacotherapy, 2019-11, Vol.53 (11), p.1124-1135

2019

Volltextzugriff (PDF)

Successful immunomodulators for the treatment of COVID-19 have opened the pathway for comparative trials

Clinical microbiology and infection, 2023-01, Vol.29 (1), p.7-9

2023

Volltextzugriff (PDF)

Ertapenem-Containing Double-Carbapenem Therapy for Treatment of Infections Caused by Carbapenem-Resistant Klebsiella pneumoniae

Antimicrobial agents and chemotherapy, 2016-01, Vol.60 (1), p.669-673

2016

Volltextzugriff (PDF)

Clinical and economic benefits of fidaxomicin compared to vancomycin for Clostridium difficile infection

Antimicrobial agents and chemotherapy, 2015-11, Vol.59 (11), p.7007-7010

2015

Volltextzugriff (PDF)

Daptomycin therapy for osteomyelitis: a retrospective study

BMC infectious diseases, 2012-06, Vol.12 (1), p.133-133, Article 133

2012

Volltextzugriff (PDF)

Antibiotic Myths for the Infectious Diseases Clinician

Clinical infectious diseases, 2023-10, Vol.77 (8), p.1120-1125

2023

Volltextzugriff (PDF)

Lessons Learned from Coronavirus Disease 2019 (COVID-19) Therapies: Critical Perspectives From the Infectious Diseases Society of America (IDSA) COVID-19 Treatment Guideline Panel

Clinical infectious diseases, 2022-05, Vol.74 (9), p.1691-1695

2022

Volltextzugriff (PDF)

Clinical outcomes in patients infected with ertapenem-only-resistant Enterobacterales versus multi-carbapenem-resistant Enterobacterales

Journal of antimicrobial chemotherapy, 2024-08, Vol.79 (8), p.1929-1937

2024

Volltextzugriff (PDF)

Transmission of Carbapenem-Resistant Klebsiella pneumoniae in US Hospitals

Clinical infectious diseases, 2023-01, Vol.76 (2), p.229-237

2023

Volltextzugriff (PDF)

The Essential Role of Pharmacists in Antimicrobial Stewardship

Infection control and hospital epidemiology, 2016-07, Vol.37 (7), p.753-754

2016

Volltextzugriff (PDF)

Case-case-control study of patients with carbapenem-resistant and third-generation-cephalosporin-resistant Klebsiella pneumoniae bloodstream infections

Antimicrobial agents and chemotherapy, 2014-10, Vol.58 (10), p.5732-5735

2014

Volltextzugriff (PDF)

Clinical impact of matrix-assisted laser desorption ionization time-of-flight mass spectrometry for the management of inpatient pneumonia without additional antimicrobial stewardship support

Infection control and hospital epidemiology, 2019-09, Vol.40 (9), p.1053-1055

2019

Volltextzugriff (PDF)

Therapeutic Emergency Use Authorizations (EUAs) During Pandemics: Double-edged Swords

Clinical infectious diseases, 2022-05, Vol.74 (9), p.1686-1690

2022

Volltextzugriff (PDF)

Pharmacodynamic and pharmacokinetic considerations in the treatment of critically Ill patients infected with carbapenem-resistant Enterobacteriaceae

Virulence, 2017-05, Vol.8 (4), p.440-452

2017

Volltextzugriff (PDF)

Poor outcomes in both infection and colonization with carbapenem-resistant Enterobacterales

Infection control and hospital epidemiology, 2022-12, Vol.43 (12), p.1840-1846

2022

Volltextzugriff (PDF)

Knowledge and Attitudes of Doctor of Pharmacy Students Regarding the Appropriate Use of Antimicrobials

Clinical infectious diseases, 2014-10, Vol.59 (suppl_3), p.S162-S169

2014

Volltextzugriff (PDF)

1 – 25 von 85

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(80)
Mit Volltextzugriff
(70)

Publikationsform

Artikel
(85)

Sprache

Englisch
(85)

Erscheinungsjahr

n.n

Thema

Science & Technology
(77)
Life Sciences & Biomedicine
(76)
Male
(28)
Female
(27)
Pharmacology & Pharmacy
(26)
Infectious Diseases
(21)
Adult
(19)
Microbiology
(19)
Anti-Bacterial Agents - Therapeutic Use
(18)
Middle Aged
(17)
Aged
(15)
Biological And Medical Sciences
(13)
Immunology
(13)
Retrospective Studies
(13)
Medical Sciences
(12)
Treatment Outcome
(12)
Risk Factors
(11)
Child
(9)
Pharmacology. Drug Treatments
(9)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Shortened Courses of Antibiotics for Bacterial Infections: A Systematic Review of Randomized Controlled Trials

Vancomycin-resistant enterococcal bacteremia pharmacotherapy

Drug Fever

Allergic cross-sensitivity between penicillin, carbapenem, and monobactam antibiotics: what are the chances?

Taking on the Fundamental Questions in Infectious Diseases Two-at-a-Time

Lack of Benefit of Fluvoxamine for COVID-19

Bacteria Keep Reminding Us: There Are No Silver Bullets

Beta-Lactam Hypersensitivity and Cross-Reactivity

β-lactam/β-lactamase inhibitor combinations: from then to now

Eravacycline: The Tetracyclines Strike Back

Successful immunomodulators for the treatment of COVID-19 have opened the pathway for comparative trials

Ertapenem-Containing Double-Carbapenem Therapy for Treatment of Infections Caused by Carbapenem-Resistant Klebsiella pneumoniae

Clinical and economic benefits of fidaxomicin compared to vancomycin for Clostridium difficile infection

Daptomycin therapy for osteomyelitis: a retrospective study

Antibiotic Myths for the Infectious Diseases Clinician

Lessons Learned from Coronavirus Disease 2019 (COVID-19) Therapies: Critical Perspectives From the Infectious Diseases Society of America (IDSA) COVID-19 Treatment Guideline Panel

Clinical outcomes in patients infected with ertapenem-only-resistant Enterobacterales versus multi-carbapenem-resistant Enterobacterales

Transmission of Carbapenem-Resistant Klebsiella pneumoniae in US Hospitals

The Essential Role of Pharmacists in Antimicrobial Stewardship

Case-case-control study of patients with carbapenem-resistant and third-generation-cephalosporin-resistant Klebsiella pneumoniae bloodstream infections

Clinical impact of matrix-assisted laser desorption ionization time-of-flight mass spectrometry for the management of inpatient pneumonia without additional antimicrobial stewardship support

Therapeutic Emergency Use Authorizations (EUAs) During Pandemics: Double-edged Swords

Pharmacodynamic and pharmacokinetic considerations in the treatment of critically Ill patients infected with carbapenem-resistant Enterobacteriaceae

Poor outcomes in both infection and colonization with carbapenem-resistant Enterobacterales

Knowledge and Attitudes of Doctor of Pharmacy Students Regarding the Appropriate Use of Antimicrobials

Aktive Filter

Suchergebnisse filtern